LDB
NWBO
Lee, Danner & Bass’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-20,000
| Closed | -$6K | – | 753 |
|
|
2024
Q3 | $6K | Hold |
20,000
| – | – | ﹤0.01% | 219 |
|
|
2024
Q2 | $9K | Buy |
+20,000
| New | +$9K | ﹤0.01% | 210 |
|
|
2023
Q4 | $14K | Hold |
20,000
| – | – | ﹤0.01% | 204 |
|
|
2023
Q3 | $18K | Hold |
20,000
| – | – | ﹤0.01% | 198 |
|
|
2023
Q2 | $11K | Hold |
20,000
| – | – | ﹤0.01% | 202 |
|
|
2023
Q1 | $12K | Hold |
20,000
| – | – | ﹤0.01% | 194 |
|
|
2022
Q4 | $16K | Hold |
20,000
| – | – | ﹤0.01% | 194 |
|
|
2022
Q3 | $14K | Hold |
20,000
| – | – | ﹤0.01% | 194 |
|
|
2022
Q2 | $13K | Hold |
20,000
| – | – | ﹤0.01% | 193 |
|
|
2022
Q1 | $14K | Hold |
20,000
| – | – | ﹤0.01% | 203 |
|
|
2021
Q4 | $14K | Hold |
20,000
| – | – | ﹤0.01% | 198 |
|
|
2021
Q3 | $26K | Hold |
20,000
| – | – | ﹤0.01% | 197 |
|
|
2021
Q2 | $29K | Hold |
20,000
| – | – | ﹤0.01% | 203 |
|
|
2021
Q1 | $30K | Hold |
20,000
| – | – | ﹤0.01% | 191 |
|
|
2020
Q4 | $30K | Hold |
20,000
| – | – | ﹤0.01% | 184 |
|
|
2020
Q3 | $15K | Hold |
20,000
| – | – | ﹤0.01% | 177 |
|
|
2020
Q2 | $7K | Hold |
20,000
| – | – | ﹤0.01% | 178 |
|
|
2020
Q1 | $3K | Hold |
20,000
| – | – | ﹤0.01% | 170 |
|
|
2019
Q4 | $4K | Hold |
20,000
| – | – | ﹤0.01% | 175 |
|
|
2019
Q3 | $5K | Hold |
20,000
| – | – | ﹤0.01% | 176 |
|
|
2019
Q2 | $5K | Hold |
20,000
| – | – | ﹤0.01% | 176 |
|
|
2019
Q1 | $5K | Hold |
20,000
| – | – | ﹤0.01% | 171 |
|
|
2018
Q4 | $4K | Hold |
20,000
| – | – | ﹤0.01% | 171 |
|
|
2018
Q3 | $4K | Hold |
20,000
| – | – | ﹤0.01% | 176 |
|
|
2018
Q2 | $5K | Hold |
20,000
| – | – | ﹤0.01% | 170 |
|
|
2018
Q1 | $5K | Hold |
20,000
| – | – | ﹤0.01% | 174 |
|
|
2017
Q4 | $5K | Hold |
20,000
| – | – | ﹤0.01% | 173 |
|
|
2017
Q3 | $4K | Buy |
+20,000
| New | +$4K | ﹤0.01% | 167 |
|